Colorectal Cancer II
Oral-21: METABEAM Study: combined analysis of concordance studies between liquid and tissue biopsies for RAS mutations in colorectal cancer patients with single metastatic sites
Date
03 Jul 2020Session
Colorectal Cancer IIPresenters
Yoshinori KagawaResources
Resources from the same session
Oral-20: Phase I/IB study of regorafenib and nivolumab in mismatch repair (MMR) proficient advanced refractory colorectal cancer
Presenter: Richard Kim
Session: Colorectal Cancer II
Resources:
Slides
Webcast
Short Oral-24: AMG 510, a novel small molecule inhibitor of KRAS G12C, for patients with advanced gastrointestinal cancers: results from the CodeBreak 100 phase 1 trial
Presenter: John Strickler
Session: Colorectal Cancer II
Resources:
Slides
Webcast
Short Oral-25: A multicenter phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer: BRAVERY study (EPOC1701)
Presenter: Toshiki Masuishi
Session: Colorectal Cancer II
Resources:
Slides
Webcast
Short Oral-26: Clinical efficacy of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer Patients
Presenter: Ryan Corcoran
Session: Colorectal Cancer II
Resources:
Slides
Webcast
Short Oral-28: A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer (mCRC)
Presenter: Jason Redman
Session: Colorectal Cancer II
Resources:
Slides
Webcast
Discussant: Oral-20, Short Oral-24, Short Oral-25, Short Oral-26, Short Oral-27, Short Oral-28
Presenter: Josep Tabernero
Session: Colorectal Cancer II
Resources:
Slides
Webcast
Late-Breaking Abstract-6: Safety, feasibility, tolerability, and preliminary efficacy of perioperative systemic therapy for resectable colorectal peritoneal metastases: pilot phase of a randomised trial (CAIRO6)
Presenter: Koen Rovers
Session: Colorectal Cancer II
Resources:
Slides
Webcast
Short Oral-29: Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: a nationwide comparative study
Presenter: Checca Bakkers
Session: Colorectal Cancer II
Resources:
Slides
Webcast
Short Oral-30: Adjuvant systemic chemotherapy versus active surveillance following upfront resection of isolated synchronous colorectal peritoneal metastases: propensity score-matched analysis of a nationwide registry.
Presenter: Koen Rovers
Session: Colorectal Cancer II
Resources:
Slides
Webcast
Short Oral-31: Centralization of care leads to optimal selection and outcomes for patients with peritoneal metastases of colorectal cancer- the Catalonian regional program experience
Presenter: Maria Isabel Ramos Bernadó
Session: Colorectal Cancer II
Resources:
Slides
Webcast